Antibodies In Ebola Survivors’ Blood Are ‘Promising Candidates’ For Therapy Development, NIH-Supported Study Shows

NIH: Broadly acting antibodies found in plasma of Ebola survivors
This NIH news release discusses results from research supported by the National Institute of Allergy and Infectious Diseases (NIAID) examining antibodies found in the blood of Ebola survivors. The news release states, “The researchers conclude that these broadly neutralizing antibodies are promising candidates for further development as therapeutic molecules against several ebolavirus species” (7/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.